AGL 40.10 Increased By ▲ 0.10 (0.25%)
AIRLINK 130.50 Increased By ▲ 0.97 (0.75%)
BOP 6.83 Increased By ▲ 0.15 (2.25%)
CNERGY 4.64 Increased By ▲ 0.01 (0.22%)
DCL 9.10 Increased By ▲ 0.16 (1.79%)
DFML 44.38 Increased By ▲ 2.69 (6.45%)
DGKC 84.19 Increased By ▲ 0.42 (0.5%)
FCCL 33.14 Increased By ▲ 0.37 (1.13%)
FFBL 77.39 Increased By ▲ 1.92 (2.54%)
FFL 11.48 Increased By ▲ 0.01 (0.09%)
HUBC 110.50 Decreased By ▼ -0.05 (-0.05%)
HUMNL 14.81 Increased By ▲ 0.25 (1.72%)
KEL 5.41 Increased By ▲ 0.02 (0.37%)
KOSM 8.35 Decreased By ▼ -0.05 (-0.6%)
MLCF 39.79 No Change ▼ 0.00 (0%)
NBP 61.24 Increased By ▲ 0.95 (1.58%)
OGDC 198.40 Decreased By ▼ -1.26 (-0.63%)
PAEL 26.80 Increased By ▲ 0.15 (0.56%)
PIBTL 7.90 Increased By ▲ 0.24 (3.13%)
PPL 158.51 Increased By ▲ 0.59 (0.37%)
PRL 26.56 Decreased By ▼ -0.17 (-0.64%)
PTC 18.51 Increased By ▲ 0.05 (0.27%)
SEARL 82.17 Decreased By ▼ -0.27 (-0.33%)
TELE 8.30 Decreased By ▼ -0.01 (-0.12%)
TOMCL 34.37 Decreased By ▼ -0.14 (-0.41%)
TPLP 9.16 Increased By ▲ 0.10 (1.1%)
TREET 17.17 Decreased By ▼ -0.30 (-1.72%)
TRG 61.25 Decreased By ▼ -0.07 (-0.11%)
UNITY 27.55 Increased By ▲ 0.12 (0.44%)
WTL 1.41 Increased By ▲ 0.03 (2.17%)
BR100 10,481 Increased By 74.5 (0.72%)
BR30 31,806 Increased By 92.4 (0.29%)
KSE100 97,873 Increased By 544.7 (0.56%)
KSE30 30,372 Increased By 179.6 (0.59%)
Pakistan

Russia offers Sputnik V COVID-19 vaccine to Pakistan

  • Ministry of Foreign Affairs received a letter to this effect along with data on the vaccine’s clinical research and trials from the Russian Embassy in Islamabad
  • Although, Sputnik V has not finished its final trials, Russia started distributing vaccinations last week
Published December 9, 2020

(Karachi) As struggle to get coronavirus vaccine gains momentum globally, Russia has offered to supply its Sputnik V COVID-19 vaccine to Pakistan, local media reported. Although, Sputnik V has not finished its final trials, the country started distributing vaccinations last week.

As per details, the Ministry of Foreign Affairs received a letter to this effect along with data on the vaccine’s clinical research and trials from the Russian Embassy in Islamabad.

The Foreign Ministry has sent the vaccine offer to the National Health Services (NHS) for further process.

Vaccine developed by Russia proved to be 92 percent effective in preventing coronavirus, the interim results showed. Russia registered Sputnik V for public use in August, the first country to do so, though the approval came before the start of the large-scale trial in September.

The Phase III trial of the shot developed by the Gamaleya Institute took place in 29 clinics across Moscow and involved 40,000 volunteers in total. The chances of contracting COVID-19 were 92% lower among people vaccinated with Sputnik V, the Russian Direct Investment Fund stated.

Comments

Comments are closed.